AKOS009341369; CHEMBL2105168; SureCN1230518; Napirimus [INN]; CTK2H9399;70696-66-1;1-methyl-4-(naphthalene-1-carbonyl)pyrrole-2-carboxylic acid; UNII-45081SG6XT; AC1MILT4; 

(2S)-2-acetamidopentanedioic
acid; ANW-52454; BOROCHEM A03-B173570; AK-41426; CTK8B6078;(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine; AKOS015919997; W4535;219921-94-5; FT-0672099; 

N-6,O-2'-Dibutyryl adenosine cyclic 3':5'-monophosphate; N-(9-beta-D-Ribofuranosyl-9H-furin-6-yl)-butyramide cyclic 3',5'-(hydrogen phosphate) 2'-butyrate;Bucladesine; 

DIBUTYRYL-CAMP;N6,2'-O-DIBUTYRYL-ADENOSINE-3':5'-MONOPHOSPHATE, CYCLIC MONOSODIUM SALT MONOHYDRATE;DIBUTYRYL-CAMP, MONOSODIUM SALT MONOHYDRATE;bucladesine;N6,2'-O-DIBUTYRYLADENOSINE 3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT MONOHYDRATE;N6,2'-O-DIBUTYRYLADENOSINE-3',5'-CYCLOPHOSPHATE SODIUM SALT MONOHYDRATE;N6,O-2μ-Dibutyryladenosine 3μ:5μ-cyclic monophosphate hydrate sodium salt;